Assignee
NIBEC CO LTD
KR·5 granted patents·12 pending applications·0 citations·filing 2017–2023
Top patents by PatentIndex Score
17 records- 0178US12486303B2Use of peptide for inhibiting functions and expressions of multiple disease biomarkersNIBEC CO LTD·Filed 2023·Granted Dec 2, 2025·0 cites·8 claims
- 0266US12545704B2Peptide for treating inflammation and woundsNIBEC CO LTD·Filed 2022·Granted Feb 10, 2026·0 cites·2 claims
- 0365US11384120B2Peptide capable of binding to biomarker for inflammatory and metabolic diseases, and use thereofNIBEC CO LTD·Filed 2019·Granted Jul 12, 2022·0 cites·8 claims
- 0462US2025134667A1Bioabsorbable and photocurable composition, bioabsorbable guided tissue regeneration composition, and grafting method using sameNIBEC CO LTD·Filed 2023·Application pending·0 cites
- 0561US2024398964A1Peptide for penetrating blood-brain barrier and use thereofNIBEC CO LTD·Filed 2022·Application pending·0 cites
- 0661US2024269302A1Nanoparticle comprising peptide-lipid conjugate for delivering oligonucleotide into target cell and pharmaceutical composition comprising sameNIBEC CO LTD·Filed 2022·Application pending·0 cites
- 0761US2025115642A1Peptide having antibacterial, anti-inflammatory or tissue regeneration ability and use thereofNIBEC CO LTD·Filed 2023·Application pending·0 cites
- 0859US11760792B2GRP78-derived peptide for identifying high-efficiency stem cellsNIBEC CO LTD·Filed 2018·Granted Sep 19, 2023·0 cites·7 claims
- 0959US2024287206A1Bio protac protein having intracellular delivery function, and pharmaceutical composition comprising sameNIBEC CO LTD·Filed 2022·Application pending·0 cites
- 1055US2023272025A1Bone morphogenetic protein-9 and -10 variants with enhanced therapeutic effect due to reduced side effects of ectopic ossification and pharmaceutical composition comprising sameNIBEC CO LTD·Filed 2021·Application pending·0 cites
- 1155US2024238368A1Peptide for preventing and treating fibrosisNIBEC CO LTD·Filed 2022·Application pending·0 cites
- 1254US2023279143A1Protein comprising antibody for targeting oncogenic protein or single chain fragment variable thereof and cancer cell penetrating peptide, and use of the sameNIBEC CO LTD·Filed 2021·Application pending·0 cites
- 1352US12161518B2Composition for treating and preventing gingivoperiodontitis or peri-implantitis, and interdental brush coated with sameNIBEC CO LTD·Filed 2018·Granted Dec 10, 2024·0 cites·9 claims
- 1451US2021340182A1Novel use of peptide for inhibiting functions and expressions of multiple disease biomarkersNIBEC CO LTD·Filed 2019·Application pending·0 cites
- 1550US2021147482A1Peptide for inhibiting bone resorptionNIBEC CO LTD·Filed 2018·Application pending·0 cites
- 1643US2021138111A1Integral biomaterial for regeneration of bone tissue and fabrication method thereforNIBEC CO LTD·Filed 2017·Application pending·0 cites
- 1742US2021009946A1Method for selecting highly efficient stem cell, using protein marker grp78NIBEC CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NIBEC CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →